Objective: The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) reported that understanding the use and impact of smokeless tobacco (SLT) products is complicated by product diversity. Many different SLT products with different characteristics are used worldwide. ZERO STYLE STIX(TM) (sold by Japan Tobacco Inc.) is a brand of snuff, a type of smokeless tobacco. Our objective was to determine the constituents of the gas from SLT and analyze the ingredients in tobacco fillers.
Methods: ZERO STYLE STIX smokeless tobacco was released in the Japanese market in 2010. Nicotine, menthol, and tobacco-specific nitrosamines in the smokeless tobacco fillers were determined by gas chromatography-mass spectrometry (GC/MS) and liquid chromatography-tandem mass spectrometry (LC/MS/MS). The gaseous compounds were collected by a smoking machine using two smoking protocols, i.e., the ISO and Health Canada Intense methods. Nicotine and menthol in the gas were determined by GC/MS.
Results: Nicotine, menthol, and the total tobacco-specific nitrosamines were detected in the tobacco fillers. The level of menthol in the snuff was more than ten times that of nicotine. The determined levels of the two components of the gas from the snuff were higher when using the Health Canada Intense protocol than when using the ISO protocol. In addition, flavors other than menthol were emitted from the smokeless tobacco.
Conclusion: The new type of snuff introduced in the Japanese market in 2010 contained added flavors, and was attractive smokeless tobacco. Flavors in tobacco products need to regulate on the basis of FCTC 9 and 10 in JAPAN.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1265/jjh.71.76 | DOI Listing |
J Educ Health Promot
November 2024
Department of Public Health Dentistry, ITS Centre for Dental Studies and Research, Murad Nagar, Ghaziabad - 201 206, Uttar Pradesh, India.
Tobacco use remains a global public health challenge, with numerous associated health risks. Behavioral modification strategies have played a pivotal role in helping individuals achieve and maintain tobacco cessation. This scoping review aims to compare different behavioral modifications for tobacco cessation counseling.
View Article and Find Full Text PDFBMJ Open
December 2024
Department of Public Health and Clinical Medicine, Piteå Research Unit, Umeå University, Umeå, Sweden
Importance: Cardiovascular health outcomes associated with noncigarette tobacco products (cigar, pipe, and smokeless tobacco) remain unclear, yet such data are required for evidence-based regulation.
Objective: To investigate the association of noncigarette tobacco products with cardiovascular health outcomes.
Design, Setting, And Participants: This cohort study was conducted within the Cross Cohort Collaboration Tobacco Working Group by harmonizing tobacco-related data and conducting a pooled analysis from 15 US-based prospective cohorts with data on the use of at least 1 noncigarette tobacco product ranging between 1948 and 2015.
Cureus
December 2024
Public Health Dentistry, Amrita School of Dentistry, Amrita Vishwa Vidyapeetham, Kochi, IND.
Introduction: Trismus is a common complication of head and neck cancer (HNC) treatment. Understanding its prevalence and its risk factors is vital for enhancing clinical outcomes and the overall quality of life of these patients.
Objective: The study aimed to assess the prevalence and the factors associated with trismus among HNC patients.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!